Search research articles
Contact Us
Filters
Showing results (131-140 of 157) with videos related to
Page
of 16
Sort By:
Journal for Immunotherapy of Cancer
|
June 15, 2021
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms
Qi Wu, Ai-Ling Tian, Bei Li, et al.
European Journal of Pharmacology
|
October 19, 2024
Escin ameliorates CUMS-induced depressive-like behavior via BDNF/TrkB/CREB and TLR4/MyD88/NF-κB signaling pathways in rats
Fengjiao Liu, Yaxin Jia, Liwei Zhao, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2023
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
Shuai Zhang, Liwei Zhao, Mengfei Guo, et al.
Oncoimmunology
|
June 30, 2023
A Chemically Defined TLR3 Agonist with Anticancer Activity
Julie Le Naour, Sylvain Thierry, Sarah Adriana Scuderi, et al.
Journal of Neuroinflammation
|
November 25, 2025
Urea functions as a risk signal driving astrocyte-mediated neuroinflammation following stroke
Yang Han, Tongshuai Zhang, Dandan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2026
Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance
Hui Pan, Zhe Shen, Liwei Zhao, et al.
Antimicrobial Agents and Chemotherapy
|
March 10, 2025
Potent antiviral activity of simnotrelvir against key epidemic SARS-CoV-2 variants with a high resistance barrier
Liwei Zhao, Chuang Li, Mengyu Wang, et al.
Cell Death and Differentiation
|
November 11, 2017
The oncolytic compound LTX-401 targets the Golgi apparatus
Heng Zhou, Allan Sauvat, Lígia C Gomes-da-Silva, et al.
Molecular Cell
|
December 2, 2019
Immunosuppression by Mutated Calreticulin Released from Malignant Cells
Peng Liu, Liwei Zhao, Friedemann Loos, et al.
Cell Death and Differentiation
|
September 3, 2016
The oncolytic compound LTX-401 targets the Golgi apparatus
Heng Zhou, Allan Sauvat, Lígia C Gomes-da-Silva, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 157) with videos related to
Sort By:
Page
of 16
Journal for Immunotherapy of Cancer
|
June 15, 2021
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms
Qi Wu, Ai-Ling Tian, Bei Li, et al.
European Journal of Pharmacology
|
October 19, 2024
Escin ameliorates CUMS-induced depressive-like behavior via BDNF/TrkB/CREB and TLR4/MyD88/NF-κB signaling pathways in rats
Fengjiao Liu, Yaxin Jia, Liwei Zhao, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2023
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
Shuai Zhang, Liwei Zhao, Mengfei Guo, et al.
Oncoimmunology
|
June 30, 2023
A Chemically Defined TLR3 Agonist with Anticancer Activity
Julie Le Naour, Sylvain Thierry, Sarah Adriana Scuderi, et al.
Journal of Neuroinflammation
|
November 25, 2025
Urea functions as a risk signal driving astrocyte-mediated neuroinflammation following stroke
Yang Han, Tongshuai Zhang, Dandan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 4, 2026
Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance
Hui Pan, Zhe Shen, Liwei Zhao, et al.
Antimicrobial Agents and Chemotherapy
|
March 10, 2025
Potent antiviral activity of simnotrelvir against key epidemic SARS-CoV-2 variants with a high resistance barrier
Liwei Zhao, Chuang Li, Mengyu Wang, et al.
Cell Death and Differentiation
|
November 11, 2017
The oncolytic compound LTX-401 targets the Golgi apparatus
Heng Zhou, Allan Sauvat, Lígia C Gomes-da-Silva, et al.
Molecular Cell
|
December 2, 2019
Immunosuppression by Mutated Calreticulin Released from Malignant Cells
Peng Liu, Liwei Zhao, Friedemann Loos, et al.
Cell Death and Differentiation
|
September 3, 2016
The oncolytic compound LTX-401 targets the Golgi apparatus
Heng Zhou, Allan Sauvat, Lígia C Gomes-da-Silva, et al.
Page
of 16